Ad is loading...
AEDCX
Price
$32.31
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
VESIX
Price
$34.70
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

AEDCX vs VESIX

Header iconAEDCX vs VESIX Comparison
Open Charts AEDCX vs VESIXBanner chart's image
Invesco EQV European Equity C
Price$32.31
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard European Stock Instl
Price$34.70
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AEDCX vs VESIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEDCX vs. VESIX commentary
Nov 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEDCX is a Buy and VESIX is a Sell.

FUNDAMENTALS
Fundamentals
VESIX has more cash in the bank: 24.5B vs. AEDCX (438M). VESIX pays higher dividends than AEDCX: VESIX (3.25) vs AEDCX (0.61). AEDCX was incepted earlier than VESIX: AEDCX (27 years) vs VESIX (25 years). AEDCX is a more actively managed with annual turnover of: 17.00 vs. VESIX (4.00). AEDCX has a lower initial minimum investment than VESIX: AEDCX (1000) vs VESIX (5000000). VESIX (8.24) and AEDCX (7.89) have marching annual gain over last year. VESIX return over 5 years is better than : 16.46 vs. AEDCX (-7.08).
AEDCXVESIXAEDCX / VESIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years25 years-
Gain YTD0.9060.93397%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets438M24.5B2%
Annual Yield % from dividends0.613.2519%
Returns for 1 year7.898.2496%
Returns for 3 years-22.07-5.73385%
Returns for 5 years-7.0816.46-43%
Returns for 10 years-0.2325.46-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DBX27.67-0.24
-0.86%
Dropbox
UK1.20-0.02
-1.64%
Ucommune International Ltd
VRNT24.67-1.03
-4.01%
Verint Systems
NB1.41-0.08
-5.37%
NioCorp Developments Ltd
ALLO2.46-0.26
-9.56%
Allogene Therapeutics